
Crude’s Crumble… And Why A Market Goldilocks Scenario Is Still In Play 12/16/25
CNBC's "Fast Money"
00:00
Pfizer Guidance, Patent Headwinds & Obesity Drugs
Panel breaks down Pfizer's weak 2026 guidance, COVID revenue decline, M&A, and MetSera's obesity positioning versus peers.
Play episode from 08:11
Transcript


